Preference for a new prefilled insulin pen compared with the original pen

References

• Centers for Disease Control and Prevention (CDC). U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf, http://www.cdc.gov/diabetes/pubs/factsheet11.htm. Accessed 18 October 2011
   Google Scholar
• Levitzky YS, Pencina MJ, D'Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008;51:264-70
   PubMed Web of Science ®Google Scholar
• Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005;28:2013-18
   PubMed Web of Science ®Google Scholar
• Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
   PubMed Web of Science ®Google Scholar
• van Melle JP, Bot M, de JP, et al. Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study. Diabetes Care 2010;33:2084-9
   PubMed Web of Science ®Google Scholar
• Chapman TM, Noble S, Goa KL. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus. Drugs 2002;62:1945-81
   PubMed Web of Science ®Google Scholar
• Perfetti R. Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use. Diabetes Technol Ther 2010;12(Suppl 1):S79-S85
   PubMed Web of Science ®Google Scholar
• Asakura T, Seino H, Nakano R, et al. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technol Ther 2009;11:657-61
   PubMed Web of Science ®Google Scholar
• Kadiri A, Chraibi A, Marouan F, et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycemic agents. Diabetes Res Clin Pract 1998;41:15-23
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-2
   PubMed Web of Science ®Google Scholar
• Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-505
   PubMed Web of Science ®Google Scholar
• Davis EM, Christensen CM, Nystrom KK, et al. Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization. Am J Health Syst Pharm 2008;65:1347-57
   PubMed Web of Science ®Google Scholar
• Hornquist JO, Wikby A, Andersson PO, et al. Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations. Diabetes Res Clin Pract 1990;10:221-30
   PubMed Web of Science ®Google Scholar
• Jefferson IG, Marteau TM, Smith MA, et al. A multiple injection regimen using an insulin injection pen and pre-filled cartridged soluble human insulin in adolescents with diabetes. Diabet Med 1985;2:493-5
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48
   PubMed Web of Science ®Google Scholar
• Asamoah E. Insulin pen-the ‘iPod’ for insulin delivery (why pen wins over syringe). J Diabetes Sci Technol 2008;2:292-6
   PubMedGoogle Scholar
• Baser O, Bouchard J, DeLuzio T, et al. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe. Adv Ther 2010;27:94-104
   PubMed Web of Science ®Google Scholar
• World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects – Last amended by the 59th WMA General Assembly, Seoul 2008. Available at: http://www.wma.net/en/30publications/10policies/b3/
   Google Scholar
• ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1), Step 4. 1996. Available at:
   Google Scholar
• EN-ISO 14155-1: 2003 Clinical Investigation of Medical Devices for Human Subjects. Part 1: General requirements. 2003
   Google Scholar
• EN-ISO 14155-2: 2003 Clinical Investigation of Medical Devices for Human Subjects. Part 2: Clinical investigation plans. 2003
   Google Scholar
• Niskanen L, Jensen LE, Rastam J, et al. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther 2004;26:531-40
   PubMed Web of Science ®Google Scholar
• Anderson RT, Skovlund SE, Marrero D, et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther 2004;26:565-78
   PubMed Web of Science ®Google Scholar
• Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Qual Life Res 2007;16:1053-63
   PubMed Web of Science ®Google Scholar
• Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16(3):297-334
   Google Scholar
• Leontitsis A, Pagge J. A Simulation Approach on Cronbach's Alpha Statistical Significance. Mathematics and Computers in Simulation 73(5). Wadsworth & Brooks/Cole, 2007:336-40
   Google Scholar
• Altman DG. Practical Statistics for Medical Research. Chapman and Hall/CRC, 1990
   Google Scholar
• Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill College, 1998
   Google Scholar
• Oyer D, Narendran P, Qvist M, et al. Ease of use and preference assessment of a new prefilled insulin pen versus a widely available prefilled insulin pen in people with diabetes, physicians and nurses. Expert Opin Drug Deliv 2011;8(10):1259-69
   PubMed Web of Science ®Google Scholar
• Bailey T, Thurman J, Niemeyer M, et al. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism. Curr Med Res Opin 2011;27(10):2043-52
   Google Scholar
• Pfutzner A, Asakura T, Sommavilla B, et al. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence. Expert Opin Drug Deliv 2008;5:915-25
   PubMed Web of Science ®Google Scholar
• Pfutzner A, Reimer T, Hohberg C, et al. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-9
   PubMed Web of Science ®Google Scholar